Profile data is unavailable for this security.
About the company
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
- Revenue in JPY (TTM)185.31bn
- Net income in JPY17.71bn
- Incorporated2021
- Employees3.39k
- LocationSawai Group Holdings Co Ltd5-2-30, Miyahara, Yodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661055818
- Websitehttps://www.sawaigroup.holdings
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Towa Pharmaceutical Co Ltd | 236.78bn | 11.74bn | 143.83bn | 4.30k | 11.71 | 0.9234 | 4.50 | 0.6075 | 238.42 | 238.42 | 4,810.52 | 3,023.62 | 0.6134 | 1.62 | 3.73 | 55,090,510.00 | 3.04 | 4.73 | 3.80 | 6.39 | 34.66 | 41.27 | 4.96 | 8.06 | 1.48 | -- | 0.5686 | 19.97 | 26.11 | 17.46 | -86.17 | -19.46 | 14.66 | 13.63 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.10bn | 2.97bn | 158.86bn | 1.13k | 44.26 | 0.9345 | 27.79 | 2.20 | 78.14 | 78.14 | 1,915.49 | 3,700.49 | 0.429 | 1.86 | 2.89 | 63,801,770.00 | 1.76 | 8.17 | 2.00 | 9.56 | 53.89 | 55.55 | 4.11 | 16.09 | 4.68 | -- | 0.0267 | 44.04 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
| Sumitomo Pharma Co Ltd | 330.31bn | -173.72bn | 165.13bn | 6.25k | -- | 0.4799 | -- | 0.4999 | -437.26 | -437.26 | 831.40 | 864.73 | 0.2717 | 1.36 | 2.71 | 52,849,120.00 | -14.95 | 1.15 | -22.20 | 1.67 | 59.93 | 72.18 | -55.04 | 2.54 | 0.3785 | -- | 0.5452 | 41.44 | -0.8019 | 3.54 | -232.08 | -- | 0.6204 | 3.13 |
| Kissei Pharmaceutical Co Ltd | 73.72bn | 12.20bn | 173.82bn | 1.80k | 13.23 | 0.7972 | 10.51 | 2.36 | 266.51 | 266.51 | 1,612.29 | 4,421.72 | 0.3213 | 1.68 | 2.60 | 41,067,970.00 | 5.38 | 3.21 | 5.87 | 3.47 | 48.23 | 52.39 | 16.74 | 11.10 | 4.51 | -- | 0.007 | 36.56 | 3.23 | -1.83 | -18.52 | 3.08 | 3.74 | 10.76 |
| Peptidream Inc | 28.71bn | 3.04bn | 197.29bn | 603.00 | 64.77 | 4.87 | 36.07 | 6.87 | 23.43 | 23.43 | 221.37 | 311.32 | 0.4307 | 4.52 | 2.66 | 47,615,580.00 | 4.55 | -- | 5.34 | -- | 59.97 | -- | 10.57 | -- | 2.88 | 2.80 | 0.3551 | -- | 6.93 | -- | -59.81 | -- | -- | -- |
| Sawai Group Holdings Co Ltd | 185.31bn | 17.71bn | 268.95bn | 3.39k | 15.23 | 1.28 | 8.47 | 1.45 | 403.17 | 348.86 | 4,219.61 | 4,800.54 | 0.4905 | 1.32 | 2.75 | 54,615,090.00 | 3.62 | 1.14 | 5.08 | 1.56 | 30.41 | 36.92 | 7.39 | 2.24 | 1.31 | 71.96 | 0.291 | 81.02 | 3.37 | 3.58 | 144.81 | -2.01 | 10.06 | 0.00 |
| Tsumura & Co | 148.79bn | 16.76bn | 291.22bn | 4.03k | 17.21 | 1.06 | 9.95 | 1.96 | 220.44 | 220.44 | 1,954.80 | 3,569.48 | 0.3633 | 0.7326 | 2.27 | 36,903,020.00 | 4.55 | 4.98 | 5.57 | 6.03 | 47.57 | 53.82 | 12.53 | 12.74 | 2.90 | -- | 0.2115 | 30.98 | 8.10 | 3.51 | -12.50 | 2.59 | 6.41 | 0.00 |
| Nippon Shinyaku Co., Ltd. | 146.98bn | 24.14bn | 301.24bn | 2.19k | 11.96 | 1.34 | 10.32 | 2.05 | 358.40 | 358.40 | 2,182.30 | 3,192.25 | 0.6128 | 1.37 | 2.97 | 67,237,880.00 | 10.07 | 10.41 | 11.44 | 12.28 | 64.60 | 59.11 | 16.43 | 15.84 | 4.49 | -- | 0.0094 | 32.10 | 4.87 | 7.28 | -8.70 | 11.98 | 22.93 | 17.00 |
| Hisamitsu Pharmaceutical Co Inc | 141.71bn | 13.97bn | 321.41bn | 2.77k | 20.86 | 1.08 | 16.40 | 2.27 | 180.93 | 180.93 | 1,840.25 | 3,497.04 | 0.441 | 3.13 | 3.43 | -- | 4.49 | 4.22 | 5.25 | 4.82 | 55.73 | 58.62 | 10.18 | 10.03 | 3.76 | -- | 0.0078 | 52.55 | 10.42 | -0.2385 | 18.97 | -6.17 | 28.90 | 0.5989 |
Data as of Apr 23 2024. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY
34.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 29 Feb 2024 | 3.87m | 8.84% |
| Nomura Asset Management Co., Ltd.as of 15 Apr 2024 | 2.75m | 6.29% |
| JPMorgan Asset Management (Japan) Ltd.as of 15 Apr 2024 | 1.71m | 3.89% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Nov 2022 | 1.47m | 3.36% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.36m | 3.10% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 15 Apr 2024 | 1.31m | 2.99% |
| Nikko Asset Management Co., Ltd.as of 30 Nov 2022 | 725.00k | 1.66% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 673.14k | 1.54% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 644.60k | 1.47% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 597.48k | 1.36% |
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
